Market Cap 71.66M
Revenue (ttm) 0.00
Net Income (ttm) -20.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 281,741
Avg Vol 951,582
Day's Range N/A - N/A
Shares Out 42.65M
Stochastic %K 39%
Beta 0.15
Analysts Strong Sell
Price Target $7.20

Company Profile

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company's drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. Its lead drug candidate is GT-02287, which is currently in...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 500 1556
Address:
4800 Montgomery Lane, Suite 220, Bethesda, United States
PaulWalter
PaulWalter Aug. 4 at 7:53 PM
$GANX I think we all have to disabuse ourselves of the notion that Khalid and Gene give a monkeys about the share price or retail. They should, because only retail is propping this up. This is Khakids last dance, he’s very rich, and is in no rush. Gene and the team are all getting paid. Not hugely, but enough. They’re all very comfortable dragging this out. I think realistically we’re 12 months away from any major catalyst, Still love the drug.
0 · Reply
MQuick
MQuick Aug. 4 at 7:45 PM
$GANX just about time for sellside to show up
0 · Reply
MQuick
MQuick Aug. 4 at 7:01 PM
$GANX they refuse to let us rise 😡
0 · Reply
MQuick
MQuick Aug. 4 at 6:30 PM
$GANX get off the damn offer algo
0 · Reply
john_Ennis
john_Ennis Aug. 4 at 5:29 PM
$GANX com on Sanofi. 1.2 billion will do it. Small change for you but you get a whole bag of new drugs you can experiment with.
1 · Reply
AtomBull27
AtomBull27 Aug. 4 at 5:15 PM
$GANX market is up a bazillion points and here we are
1 · Reply
Jeffreyb7173
Jeffreyb7173 Aug. 4 at 5:11 PM
$GANX the worst part about this stock has been the opportunity cost.., watching other stocks go up 10,20,30x… stocks hitting new highs While we sit here.., down 80% from ipo… Too late now to do anything but cross my fingers and hope they pull of a huge partnership
3 · Reply
Jeffreyb7173
Jeffreyb7173 Aug. 4 at 4:48 PM
$GANX it’s time for Khalid to say something, anything!
2 · Reply
MarkeTimer
MarkeTimer Aug. 4 at 4:40 PM
$GANX unbelievable this doesn't even get a sympathetic move, for the indices, especially spy, up 500 Handles in 2 weeks. Bring it, gene.
0 · Reply
MQuick
MQuick Aug. 4 at 4:40 PM
$GANX stock is worth $10 minimum right now. The market can go screw itself!
1 · Reply
Latest News on GANX
Gain Therapeutics Slides: Corporate presentation

Jun 9, 2026, 7:00 AM EDT - 2 months ago

Gain Therapeutics Slides: Corporate presentation


Gain Therapeutics presents data from Phase 1b study of GT-02287

2026-05-26T14:58:26.000Z - 2 months ago

Gain Therapeutics presents data from Phase 1b study of GT-02287


Gain Therapeutics Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Gain Therapeutics Earnings release: Q1 2026


Gain Therapeutics Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Gain Therapeutics Quarterly report: Q1 2026


Gain Therapeutics reports Q1 EPS (13c), consensus (14c)

2026-05-11T11:47:50.000Z - 3 months ago

Gain Therapeutics reports Q1 EPS (13c), consensus (14c)


Gain Therapeutics Slides: Corporate presentation

May 5, 2026, 7:00 AM EDT - 3 months ago

Gain Therapeutics Slides: Corporate presentation


Gain Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Gain Therapeutics Proxy statement: Proxy filing


Gain Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Gain Therapeutics Proxy statement: Proxy filing


Gain Therapeutics management to meet with Maxim

2026-04-17T16:20:14.000Z - 3 months ago

Gain Therapeutics management to meet with Maxim


Gain Therapeutics Slides: Corporate presentation

Apr 8, 2026, 7:00 AM EDT - 4 months ago

Gain Therapeutics Slides: Corporate presentation


Gain Therapeutics Annual report: Q4 2025

Mar 26, 2026, 4:00 PM EDT - 4 months ago

Gain Therapeutics Annual report: Q4 2025


Gain Therapeutics Earnings release: Q4 2025

Mar 26, 2026, 4:00 PM EDT - 4 months ago

Gain Therapeutics Earnings release: Q4 2025


Gain Therapeutics reports Q4 EPS (61c), consensus (14c)

2026-03-26T11:26:07.000Z - 4 months ago

Gain Therapeutics reports Q4 EPS (61c), consensus (14c)


Gain Therapeutics Transcript: The 38th Annual Roth Conference

Mar 24, 2026, 1:30 PM EDT - 4 months ago

Gain Therapeutics Transcript: The 38th Annual Roth Conference


Gain Therapeutics to Present at the 38th Annual ROTH Conference

Mar 19, 2026, 4:57 PM EDT - 4 months ago

Gain Therapeutics to Present at the 38th Annual ROTH Conference


Gain Therapeutics provides regulatory update on GT-02287

2026-03-12T11:32:59.000Z - 5 months ago

Gain Therapeutics provides regulatory update on GT-02287


Gain Therapeutics Slides: Corporate presentation

Mar 8, 2026, 7:00 AM EDT - 5 months ago

Gain Therapeutics Slides: Corporate presentation


Gain Therapeutics Transcript: Study Update

Jan 6, 2026, 10:00 AM EST - 7 months ago

Gain Therapeutics Transcript: Study Update


Gain Therapeutics Press release: Study Update

Jan 6, 2026, 10:00 AM EST - 7 months ago

Gain Therapeutics Press release: Study Update


Gain Therapeutics holds a conference call

2025-12-30T16:00:13.000Z - 7 months ago

Gain Therapeutics holds a conference call


Gain Therapeutics presents data on GT-02287

2025-11-20T12:05:27.000Z - 9 months ago

Gain Therapeutics presents data on GT-02287


Gain Therapeutics reports Q3 EPS (15c), consensus (15c)

2025-11-12T12:15:51.000Z - 9 months ago

Gain Therapeutics reports Q3 EPS (15c), consensus (15c)


Gain Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Gain Therapeutics Earnings release: Q3 2025


Gain Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Gain Therapeutics Quarterly report: Q3 2025


Gain Therapeutics Registration statement: Registration Filing

Nov 7, 2025, 7:00 AM EST - 9 months ago

Gain Therapeutics Registration statement: Registration Filing


Gain Therapeutics to Present at Neuroscience 2025

Oct 30, 2025, 7:00 AM EDT - 9 months ago

Gain Therapeutics to Present at Neuroscience 2025


Gain Therapeutics price target lowered to $5 from $9 at BTIG

2025-10-16T11:45:35.000Z - 10 months ago

Gain Therapeutics price target lowered to $5 from $9 at BTIG


Gain Therapeutics to Attend the 2025 Maxim Growth Summit

Oct 16, 2025, 7:00 AM EDT - 10 months ago

Gain Therapeutics to Attend the 2025 Maxim Growth Summit


Gain Therapeutics Transcript: Study Result

Oct 14, 2025, 4:00 PM EDT - 10 months ago

Gain Therapeutics Transcript: Study Result


Gain Therapeutics price target raised to $7 from $5 at Maxim

2025-10-07T13:10:58.000Z - 10 months ago

Gain Therapeutics price target raised to $7 from $5 at Maxim


Gain Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Gain Therapeutics Quarterly report: Q2 2025


Gain Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Gain Therapeutics Earnings release: Q2 2025


Gain Therapeutics Announces Proposed Public Offering

Jul 15, 2025, 4:36 PM EDT - 1 year ago

Gain Therapeutics Announces Proposed Public Offering


Gain Therapeutics Registration statement: Registration Filing

May 28, 2025, 8:00 AM EDT - 1 year ago

Gain Therapeutics Registration statement: Registration Filing


Gain Therapeutics Earnings release: Q1 2025

May 14, 2025, 4:00 PM EDT - 1 year ago

Gain Therapeutics Earnings release: Q1 2025


Gain Therapeutics Quarterly report: Q1 2025

May 14, 2025, 4:00 PM EDT - 1 year ago

Gain Therapeutics Quarterly report: Q1 2025


Gain Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Gain Therapeutics Proxy statement: Proxy Filing


Gain Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Gain Therapeutics Proxy statement: Proxy Filing


Gain Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Gain Therapeutics Proxy statement: Proxy Filing


Gain Therapeutics Announces Poster Presentation at AD/PD 2025

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Gain Therapeutics Announces Poster Presentation at AD/PD 2025


Gain Therapeutics Annual report: Q4 2024

Mar 27, 2025, 1:30 PM EDT - 1 year ago

Gain Therapeutics Annual report: Q4 2024


Gain Therapeutics Earnings release: Q4 2024

Mar 27, 2025, 1:30 PM EDT - 1 year ago

Gain Therapeutics Earnings release: Q4 2024


Gain Therapeutics Announces Oral Presentation at AD/PD 2025

Mar 6, 2025, 7:55 AM EST - 1 year ago

Gain Therapeutics Announces Oral Presentation at AD/PD 2025


Gain Therapeutics To Present At Biotech Showcase 2025

Dec 11, 2024, 8:30 AM EST - 1 year ago

Gain Therapeutics To Present At Biotech Showcase 2025


Gain Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 12:00 AM EST - 1 year ago

Gain Therapeutics Quarterly report: Q3 2024


Gain Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 12:00 AM EST - 1 year ago

Gain Therapeutics Earnings release: Q3 2024


Gain Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Gain Therapeutics Quarterly report: Q2 2024


Gain Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Gain Therapeutics Earnings release: Q2 2024


PaulWalter
PaulWalter Aug. 4 at 7:53 PM
$GANX I think we all have to disabuse ourselves of the notion that Khalid and Gene give a monkeys about the share price or retail. They should, because only retail is propping this up. This is Khakids last dance, he’s very rich, and is in no rush. Gene and the team are all getting paid. Not hugely, but enough. They’re all very comfortable dragging this out. I think realistically we’re 12 months away from any major catalyst, Still love the drug.
0 · Reply
MQuick
MQuick Aug. 4 at 7:45 PM
$GANX just about time for sellside to show up
0 · Reply
MQuick
MQuick Aug. 4 at 7:01 PM
$GANX they refuse to let us rise 😡
0 · Reply
MQuick
MQuick Aug. 4 at 6:30 PM
$GANX get off the damn offer algo
0 · Reply
john_Ennis
john_Ennis Aug. 4 at 5:29 PM
$GANX com on Sanofi. 1.2 billion will do it. Small change for you but you get a whole bag of new drugs you can experiment with.
1 · Reply
AtomBull27
AtomBull27 Aug. 4 at 5:15 PM
$GANX market is up a bazillion points and here we are
1 · Reply
Jeffreyb7173
Jeffreyb7173 Aug. 4 at 5:11 PM
$GANX the worst part about this stock has been the opportunity cost.., watching other stocks go up 10,20,30x… stocks hitting new highs While we sit here.., down 80% from ipo… Too late now to do anything but cross my fingers and hope they pull of a huge partnership
3 · Reply
Jeffreyb7173
Jeffreyb7173 Aug. 4 at 4:48 PM
$GANX it’s time for Khalid to say something, anything!
2 · Reply
MarkeTimer
MarkeTimer Aug. 4 at 4:40 PM
$GANX unbelievable this doesn't even get a sympathetic move, for the indices, especially spy, up 500 Handles in 2 weeks. Bring it, gene.
0 · Reply
MQuick
MQuick Aug. 4 at 4:40 PM
$GANX stock is worth $10 minimum right now. The market can go screw itself!
1 · Reply
DonkeyClanbrands
DonkeyClanbrands Aug. 4 at 4:39 PM
$GANX 43 stocks on my watchlist and of course ganx is only one in red
0 · Reply
GordonGeiko
GordonGeiko Aug. 4 at 4:09 PM
$GANX $BYND has a $330M market cap against $74M for Gain. Fake meat or getting your sense of smell back?
0 · Reply
SevenPhigs27
SevenPhigs27 Aug. 4 at 2:49 PM
$GANX Took a starter GLTA
1 · Reply
MrBlockchain
MrBlockchain Aug. 4 at 2:41 PM
$GANX Dead until it ain't.
0 · Reply
Bach_A
Bach_A Aug. 4 at 2:35 PM
0 · Reply
MQuick
MQuick Aug. 4 at 2:23 PM
$GANX so damn annoying
2 · Reply
MQuick
MQuick Aug. 4 at 1:46 PM
$GANX cap makes no sense
0 · Reply
mwb1
mwb1 Aug. 4 at 1:39 PM
$GANX We know from clinical research the Rex/2287 improves mitochondrial function, mytophagy, oxidative stress, lysosomal biology, inflammatory pathways, etc, through improving Gcase function. For whatever reason, there hasn’t been as much research on reduced Gcase function in Alzheimer’s as there has been in Parkinson’s. But there has been some research. And it’s pretty strong. The article that @microcapspeculator shared doesn’t mention Gcase, but there’s a good chance that there is a link: https://pmc.ncbi.nlm.nih.gov/articles/PMC4668030/
1 · Reply
microcapspeculator
microcapspeculator Aug. 4 at 1:27 PM
$GANX Well GT-02287 works on improving Ceramide levels. Elevated brain ceramide levels cause synaptic dysfunction by impairing neurotransmission, reducing receptor responses, and promoting structural neurodegeneration. These bioactive lipids trigger long-term depression of synaptic currents and disrupt plasticity essential for cognition. Parkinson's gene linked to early dysfunction in brain cells https://medicalxpress.com/news/2026-08-parkinson-gene-linked-early-dysfunction.html#goog_rewarded The findings support the growing idea that synaptic dysfunction, rather than neuron death itself, may be one of the earliest events in Parkinson's disease
0 · Reply
MQuick
MQuick Aug. 4 at 11:56 AM
$GANX my spidey sense tells me something is close
0 · Reply
DonkeyClanbrands
DonkeyClanbrands Aug. 4 at 11:23 AM
$GANX BIG pharma Has some of the smartest most educated doctors/scientists on staff- clearly we dont have a partner and our valuation are what they are for a reason- I pray this changes but how about a wake up to reality.. love to hear what I am missing as I have over 75k shares and no intentions of selling- so save the blocks, or comments that I am FUD DONKEY LOL
6 · Reply
MQuick
MQuick Aug. 4 at 11:05 AM
0 · Reply